2023
DOI: 10.2147/ijn.s407029
|View full text |Cite
|
Sign up to set email alerts
|

Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases

Abstract: Exosomes are nanovesicles with a wide range of chemical compositions used in many different applications. Mesenchymal stem cell-derived exosomes (MSCs-EXOs) are spherical vesicles that have been shown to mediate tissue regeneration in a variety of diseases, including neurological, autoimmune and inflammatory, cancer, ischemic heart disease, lung injury, and liver fibrosis. They can modulate the immune response by interacting with immune effector cells due to the presence of anti-inflammatory compounds and are … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(2 citation statements)
references
References 416 publications
(400 reference statements)
0
2
0
Order By: Relevance
“…As regulators of the TME, MSCs release exosomes and their involvement in tumor occurrence and metastasis is controlled by many growth factor receptors, including EGFR and PDGFR. 129 Elevated ITGA6 expression is correlated with unfavorable overall survival in patients with CRC. Exosomes derived from MSCs carrying miR-3940-5p target ITGA6 and subsequently deactivate TGF-β1, thereby inhibiting invasion and EMT of CRC cells, as well as suppressing tumor growth and metastasis.…”
Section: Other Cells-derived Exosomesmentioning
confidence: 99%
“…As regulators of the TME, MSCs release exosomes and their involvement in tumor occurrence and metastasis is controlled by many growth factor receptors, including EGFR and PDGFR. 129 Elevated ITGA6 expression is correlated with unfavorable overall survival in patients with CRC. Exosomes derived from MSCs carrying miR-3940-5p target ITGA6 and subsequently deactivate TGF-β1, thereby inhibiting invasion and EMT of CRC cells, as well as suppressing tumor growth and metastasis.…”
Section: Other Cells-derived Exosomesmentioning
confidence: 99%
“…Moreover, they can be engineered to target specific cells or tissues, enhancing drug selectivity and efficacy 8 , 9 . Numerous studies have explored the potential of MSC-Exos as drug delivery vehicles, including delivering anti-inflammatory medications for conditions like arthritis and inflammatory bowel disease, as well as therapeutic compounds for cardiovascular diseases 10 .…”
Section: Introductionmentioning
confidence: 99%